Initial Ibrutinib Dose and Its Modification Do Not Affect Survival in Patients with CLL
Researchers found that in patients with chronic lymphocytic leukemia receiving commercial ibrutinib, initial dose and dose modification during therapy did not appear to impact event-free survival or overall survival. (Source: CancerNetwork)
Source: CancerNetwork - April 6, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Approves Luspatercept to Treat Anemia in Patients with Lower-Risk MDS
The FDA approved the first and only erythroid maturation agent for the treatment of anemia in patients with lower-risk myelodysplastic syndromes. (Source: CancerNetwork)
Source: CancerNetwork - April 6, 2020 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news
Anthony S. Fauci, MD, on How Physicians Can Talk to Patients About COVID-19
The director of the National Institute of Allergy and Infectious Diseases spoke with The New England Journal of Medicine in a podcast about how physicians can approach talking to patients regarding COVID-19. (Source: CancerNetwork)
Source: CancerNetwork - April 5, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
COVID-19 May Be Less Severe in Pediatric Patients
Two separate studies of pediatric patients in Wuhan, China found that though clinical manifestations of COVID-19 in children were less severe than those of adult patients, young children, particularly infants, were vulnerable to the infection. (Source: CancerNetwork)
Source: CancerNetwork - April 4, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
AACR Calls for Immediate Action Against COVID-19 from Congress for Patients with Cancer
In a letter to Congress, the AACR called for immediate action to be taken to protect patients with cancer against the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - April 3, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Grants Fast Track Designation to PI3K Inhibitor ME-401 for Patients with FL
The FDA granted fast track designation to ME-401, an investigational selective oral inhibitor of PI3K delta, for the treatment of adult patients with relapsed or refractory follicular lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - April 3, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Pembrolizumab Induces Significantly Improved PFS in MSI-H/dMMR Colorectal Cancer
The trial evaluating the first-line treatment of pembrolizumab in patients with microsatellite instability-high or mismatch repair deficient unresectable or metastatic colorectal cancer demonstrated improved PFS compared with chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - April 3, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Accepts IND for NK Cell Therapy CYNK-001 to Treat Patients with COVID-19
The FDA cleared the investigational new drug (IND) application for the use of CYNK-001 in adults with COVID-19. (Source: CancerNetwork)
Source: CancerNetwork - April 3, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Updated Results for Infigratinib in Metastatic Urothelial Cancer
Researchers reported updated findings of infigratinib in upper tract urothelial carcinoma and urothelial carcinoma of the bladder, supporting the development of phase III studies in this setting. (Source: CancerNetwork)
Source: CancerNetwork - April 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Clinicians Discuss Best Approaches for Treating Patients with Cancer During COVID-19 Pandemic
Clinicians advised the best approaches for treating patients who have been diagnosed or are currently under treatment for cancer during the ongoing COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - April 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
American Nurses Association Discusses PPE Equipment During COVID-19 Pandemic
In a webinar hosted by the American Nurses Association, Terri Rebmann, PhD, RN, CIC, FAPIC, discussed how nurses can protect themselves and their patients during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - April 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
New Blood Test Could Detect More Than 50 Cancer Types
A study found that, utilizing cell-free DNA sequencing leveraging methylation patterns, a new blood test could detect more than 50 cancer types and the location of these cancer types in the body. (Source: CancerNetwork)
Source: CancerNetwork - April 2, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Jeffrey S. Weber, MD, PhD, Discusses Anti-IL-6 Agents in Treating COVID-19-Induced Pneumonia
The deputy director at NYU Langone ’s Perlmutter Cancer Center explained the importance of these agents and the development of clinical trials in this setting. (Source: CancerNetwork)
Source: CancerNetwork - April 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Natural Tissue Versus Implant-Based Breast Reconstruction: Knowing the Differences
Plastic surgeon and breast specialist Dr. Constance Chen discussed the potential complications of implant-based breast reconstruction, and how it compares to natural tissue reconstruction. (Source: CancerNetwork)
Source: CancerNetwork - April 1, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Practical Measures to Prevent COVID-19, According to NEJM
In a podcast, published by The New England Journal of Medicine (NEJM), physicians discuss practical measures that could help prevent the coronavirus disease 2019 (COVID-19). (Source: CancerNetwork)
Source: CancerNetwork - April 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
